p53 and p16(Ink4a)/p19(Arf) Loss Promotes Different Pancreatic Tumor Types from PyMT-Expressing Progenitor Cells()()

In human studies and mouse models, the contributions of p53 and p16(Ink4a)/p19(Arf) loss are well established in pancreatic ductal adenocarcinoma (PDAC). Although loss of functional p53 pathway and loss of Ink4a/Arf in human pancreatic acinar cell carcinoma (PACC) and pancreatic neuroendocrine tumor...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neoplasia
Egile Nagusiak: Azzopardi, Stephanie, Pang, Sharon, Klimstra, David S., Du, Yi-Chieh Nancy
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Neoplasia Press 2016
Gaiak:
Original article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5035259/
https://ncbi.nlm.nih.gov/pubmed/27664376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2016.08.003
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak